The differential expression of Cxcl10 and Cxcl9 in tumor vs. spleen likely reflects different composition of myeloid cells and raises the possibility that the chemokines may play a differential role in the TEFF vs. TEX fate choice. This evidence concerns the gene CXCL9 and neoplasm.